Market Introduction
Neurovascular devices are used to treat neurovascular diseases that possibly affect the network of blood vessels that surround the brain. Neurovascular disorders lead to incurable conditions such as strokes and aneurysms. Neurovascular devices are used to prevent stroke, aneurysm embolization, carotid stenosis, and other symptoms. Neurovascular devices are also used for performing surgical procedures to treat aneurysms and other cranial blood flow problems.
Market Overview and Dynamics
The Europe neurovascular devices market is expected to reach US$ 773.41 Mn in 2027 from US$ 999.65 Mn in 2019. The market is estimated to grow with a CAGR of 3.4% from 2020-2027. Key factors that are driving growth of Europe Neurovascular Devices market are Increasing Incidences of neurovascular diseases, rising demand for minimally invasive procedures, and significantly growing aging population. However, the market is expected to grow at slower pace owing to the factors such as high cost of embolization coils and lack of expert professionals operating neurovascular disorders.
Key Market Segments
The Europe neurovascular devices market, based on the product was segmented into neurothrombectomy devices, aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems and support devices. The aneurysm coiling & embolization devices held the largest share of the market in 2019, and is anticipated to register the highest CAGR in the market during the forecast period.
The Europe neurovascular devices market, based on the application was segmented into cerebral aneurysms, ischemic strokes, arteriovenous malformation & fistulas, and other applications. In 2019, ischemic strokes segment held the largest share of the market and is expected to register the highest CAGR in the market during the forecast period.
Based on end user, the Europe neurovascular devices market, was segmented into hospitals, ambulatory surgical centers and specialized clinics. In 2019, hospitals segment held the largest share of the market and is registered to dominate the market at the highest CAGR during the forecast period.
Major Sources and Companies Listed
Some of the major primary and secondary sources for Europe neurovascular devices market included in the report are Societa Italiana Di Neuroscienze (SINS); Agenzia Sanitaria e Sociale Regionale (ASSR); World Stroke Organisation (WSO); and World Health Organisation (WHO); among others.
Reasons to buy the report
- To understand the Europe neurovascular devices market scope and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe neurovascular devices market.
- Efficiently plan M&A and partnership deals in Europe neurovascular devices market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe neurovascular devices market.
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in Europe.
Europe North America Neurovascular Devices market –
- Neurothrombectomy Devices
- Clot Retrieval Devices
- Suction & Aspiration Devices
- Snares
- Aneurysm Coiling & Embolization Devices
- Embolic Coils
- Bare Detachable Coils
- Coated Detachable Coils
- Flow Diversion Devices
- Liquid Embolic Agents
- Embolic Coils
- Cerebral Balloon Angioplasty & Stenting Systems
- Carotid Artery Stents
- Embolic Protection Systems
- Balloon Occlusion Devices
- Distal Fillers
- Support Devices
- Microcatheters
- Microguidewires
- Cerebral Aneurysms
- Arteriovenous Malformation & Fistulas
- Other Applications
- Hospitals
- Ambulatory Surgical Centers
- Specialized Clinics
By Country
- UK
- Germany
- Spain
- Italy
- France
Company Profiles
- Medtronic plc
- Johnson and Johnson, Inc (DePuy Synthes)
- Penumbra, Inc
- Terumo Corporation
- MicroPort Scientific Corporation
- Integer Holdings Corporation
- Memry Corporation
- Phenox GmbH